[at Seeking Alpha] - Daniel R. Passeri Yes, thanks Ali. I'll begin with Erivedge, which is being developed and commercialized globally by Genentech and Roche, under our collaboration. The third quarter was marked by the continued ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment